Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter

European Journal of Pharmacology

Volumn 298, Issue 1, 1996, Pages 27-30

  Gordon, Irit ^a   Weizman, Ronit ^a   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amantadine; Benztropine; Dopamine transporter; L DOPA; Reserpine; 3H GBR 12935 binding

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; AMANTADINE; BENZATROPINE; CARBIDOPA; DOPA; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; LEVODOPA; MAZINDOL; RADIOLIGAND; RESERPINE;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LIGAND BINDING; MALE; MONOAMINE METABOLISM; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

EID: 0030051113     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00770-9     Document Type: Article

References (15)

1. 3H]GBR 12935 binding after chronic treatment with dopamine active drugs, Psychopharmacology 102, 291.
2. Boulay, D., I. Leroux-Nicollet, D. Duterte-Boucher, L. Naudon and J. Costentin, 1994, Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783, J. Neural Transm. 98, 209.
3. Brannan, T., J. Martinez-Tica and M.D. Yahr, 1991, Effect of long-term L-dopa administration on striatal extracellular dopamine release, Neurology 41, 596.
4. Coyle, J.T. and S.H. Snyder, 1969, Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecifity in different areas, J. Pharmacol. Exp. Ther. 170, 221.
5. 3H]mazindol binding sites in rat striatum by dopaminergic agents, Eur. J. Pharmacol. 250, 261.
6. Jackisch, R., T. Link, B. Neufang and R. Koch, 1992, Studies on the mechanism of action of the antiparkinsonian drugs memeantine and amantadine: no evidence for direct dopaminomimetic of antimuscarinic properties, Arch. Intern. Pharmacodyn. Ther. 320, 21.
7. 3H]GBR 12935 in brain. A radioligand for selective labelling of the dopamine transporter complex, J. Neurochem. 46, 1272.
8. 18F]GBR 13119 binding to the dopamine uptake site, Eur. J. Pharmacol. 216, 109.
9. Klawans, H.L., C. Goetry, P.A. Nausieda and W.J. Weiner, 1977, Levedopa-induced dopamine receptor hypersensitivity, Trans. Am. Neurol. Assoc. 102, 80.
10. Kula, N.S. and R.J. Baldessarini, 1991, Lack of increase in dopamine transporter binding on function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine, Neuropharmacology 30(1), 89.
11. Lee, C.M., J.A. Javitch and S.H. Snyder, 1983, Recognition sites for norepinephrine uptake: regulation by neurotransmitter, Science 220, 626.
12. 3H]hemicholinium-3 binding sites in rat brain, Brain Res. 381, 191.
13. Neisewander, J.L., I. Lucki and P. McGonigle, 1991, Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats, J. Pharmacol. Exp. Ther. 257(2), 850.
14. 3H]GBR 12783 binding in vivo, Eur. J. Pharmacol. 178, 221.
15. Wiener, H.L., A. Hashim, A. Lajtha and S. Sershen, 1989, Chronic L-deprenyl induced up-regulation of the dopamine uptake carrier, Eur. J. Pharmacol. 163, 191.